Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Results from TRIUMPH-1, 2, and 3 are expected throughout 2026
Implications for employers: GLP-1 drugs appear to reduce cardiovascular risk in patients with diabetes
It facilitates the transport of long-chain fatty acids into mitochondria, enhancing energy production and supporting overall metabolism (National Institutes of Health, 2023)
doi: 10.3389/fnut.2026.1778473 Received 31 December 2025 Revised 09 March 2026 Accepted 26 March 2026 Published 28 April 2026 Volume 13 - 2026 Edited by Huanling Lai, Guangzhou National Laboratory, China Reviewed by Jiayi Zhou, University of North Carolina at Chapel Hill, United States Mairepaiti Halimulati, The University of Texas at Austin, United States Updates Copyright 2026 Sun, Sun, Nan, Wang, Sun, Shi, Yang and Wang
US$ 20.90
US$ 23.01
US$ 22.12
US$ 28.42
US$ 21.09
US$ 27.95
US$ 24.14
US$ 28.69
US$ 28.12
